Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s ...

Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to ...

The “F**k the Nazis” series is back this summer for another celebration of good triumphing over a purely evil ideology, running through June 10 with a collection of nine movies ranging from high ...

Q1 2025 Earnings Call Transcript May 13, 2025 Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Each student in the Undergraduate Research Scholars Program worked with a faculty mentor throughout the academic year, developing a proposal, conducting research and presenting their findings through ...

The Council of Europe project “Supporting democratic post-war elections in Ukraine – Phase II” (hereinafter “the Project”), ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...

Acclaimed filmmaker Mr Raymond Tan, director of Malaysia’s first landmark big-screen wildlife documentary Itam: A Sun Bear ...

Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising ...

Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital MarketsScott Smith ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...